HIGHLIGHTS: Thomas Schinecker - CEO of Roche
In Good Company with Nicolai Tangen
Europe's Declining Role in Global Drug Trials
This chapter explores Europe's diminishing role in clinical drug trials in comparison to the United States and China, noting a significant drop in market share. It highlights the impact of better startup environments and venture capital access in the US, along with bureaucratic obstacles in Europe that hinder the pace of clinical innovation.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
